Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Negative Symptoms of Schizophrenia
Clinical trial NCT03896945 · TERMINATED
Trial details
- NCT number
- NCT03896945
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-15
- Primary completion
- 2023-05-23
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.